64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions

Saved in:
Bibliographic Details
Main Authors: Rishabh Singh, Ishan J. Tatake, Joseph Sibley, Radhika Gangaraju, Karlyn A. Martin, Rachel P. Rosovsky, Diana Marie Byrnes, Ming Y. Lim, Manila Gaddh, Jacob Cogan, Kimberley Youkhana, Lisa Baumann Kreuziger, Andrew M. Peseski
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Research and Practice in Thrombosis and Haemostasis
Online Access:http://www.sciencedirect.com/science/article/pii/S2475037925001372
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850232214666608640
author Rishabh Singh
Ishan J. Tatake
Joseph Sibley
Radhika Gangaraju
Karlyn A. Martin
Rachel P. Rosovsky
Diana Marie Byrnes
Ming Y. Lim
Manila Gaddh
Jacob Cogan
Kimberley Youkhana
Lisa Baumann Kreuziger
Andrew M. Peseski
author_facet Rishabh Singh
Ishan J. Tatake
Joseph Sibley
Radhika Gangaraju
Karlyn A. Martin
Rachel P. Rosovsky
Diana Marie Byrnes
Ming Y. Lim
Manila Gaddh
Jacob Cogan
Kimberley Youkhana
Lisa Baumann Kreuziger
Andrew M. Peseski
author_sort Rishabh Singh
collection DOAJ
format Article
id doaj-art-10a5143a037c46d0a18da76233dbbb3b
institution OA Journals
issn 2475-0379
language English
publishDate 2025-05-01
publisher Elsevier
record_format Article
series Research and Practice in Thrombosis and Haemostasis
spelling doaj-art-10a5143a037c46d0a18da76233dbbb3b2025-08-20T02:03:16ZengElsevierResearch and Practice in Thrombosis and Haemostasis2475-03792025-05-01910281310.1016/j.rpth.2025.10281364 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic InstitutionsRishabh Singh0Ishan J. Tatake1Joseph Sibley2Radhika Gangaraju3Karlyn A. Martin4Rachel P. Rosovsky5Diana Marie Byrnes6Ming Y. Lim7Manila Gaddh8Jacob Cogan9Kimberley Youkhana10Lisa Baumann Kreuziger11Andrew M. Peseski12University of Illinois College of Medicine Peoria, Peoria, IL, USABeth Israel Deaconess Medical Center, Brookline, MA, USABlood Research Institute, Versiti, Milwaukee, WI, USAUniversity of Alabama at Birmingham, Birmingham, AL, USAUniversity of Vermont Larner College of Medicine, Burlington, VT, USAMassachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USAUniversity of Miami , Miami, FL, USAUniversity of Utah Health, Salt Lake City, UT, USAEmory University School of Medicine, Atlanta, GA, USAUniversity of Minnesota, Minneapolis, MN, USAMedical University of South Carolina, Charleston, SC, USABlood Research Institute, Versiti, Milwaukee, WI, USA; Medical College of Wisconsin, Milwaukee, WI, USADuke University Medical Center, Durham, NC, USAhttp://www.sciencedirect.com/science/article/pii/S2475037925001372
spellingShingle Rishabh Singh
Ishan J. Tatake
Joseph Sibley
Radhika Gangaraju
Karlyn A. Martin
Rachel P. Rosovsky
Diana Marie Byrnes
Ming Y. Lim
Manila Gaddh
Jacob Cogan
Kimberley Youkhana
Lisa Baumann Kreuziger
Andrew M. Peseski
64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
Research and Practice in Thrombosis and Haemostasis
title 64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
title_full 64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
title_fullStr 64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
title_full_unstemmed 64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
title_short 64 Variation in Anticoagulant Hemorrhage Management Guidelines for Factor-Xa Inhibitors: A Survey and Analysis of U.S. Academic Institutions
title_sort 64 variation in anticoagulant hemorrhage management guidelines for factor xa inhibitors a survey and analysis of u s academic institutions
url http://www.sciencedirect.com/science/article/pii/S2475037925001372
work_keys_str_mv AT rishabhsingh 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT ishanjtatake 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT josephsibley 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT radhikagangaraju 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT karlynamartin 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT rachelprosovsky 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT dianamariebyrnes 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT mingylim 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT manilagaddh 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT jacobcogan 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT kimberleyyoukhana 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT lisabaumannkreuziger 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions
AT andrewmpeseski 64variationinanticoagulanthemorrhagemanagementguidelinesforfactorxainhibitorsasurveyandanalysisofusacademicinstitutions